IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.56) per share.
Big Lots Sees Q4 Comps To Decline Low-Double-Digit Range
Company Outlook
For the fourth quarter, the company expects comps to be down in the low-double-digit range. Net new stores will add about 170 basis points of growth versus 2021. The company expects the fourth quarter